Allergan Says Imprimis' Bad Faith Discovery Merits Sanctions
Allergan USA Inc. urged a California federal court Monday to sanction Imprimis Pharmaceuticals Inc. for violating a discovery order in a false advertising case by refusing to hand over documents in...To view the full article, register now.
Already a subscriber? Click here to view full article